Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 2;25(11):euad342.
doi: 10.1093/europace/euad342.

Left atrial appendage occlusion in chronic kidney disease: opening the way to randomized trials

Affiliations
Comment

Left atrial appendage occlusion in chronic kidney disease: opening the way to randomized trials

Odysseas Katsaros et al. Europace. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment on

  • Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion.
    Della Rocca DG, Magnocavallo M, Van Niekerk CJ, Gilhofer T, Ha G, D'Ambrosio G, Mohanty S, Gianni C, Galvin J, Vetta G, Lavalle C, Di Biase L, Sorgente A, Chierchia GB, de Asmundis C, Urbanek L, Schmidt B, Geller JC, Lakkireddy DR, Mansour M, Saw J, Horton RP, Gibson D, Natale A. Della Rocca DG, et al. Europace. 2023 Nov 2;25(11):euad315. doi: 10.1093/europace/euad315. Europace. 2023. PMID: 37889200 Free PMC article.

References

    1. Della Rocca DG, Magnocavallo M, Van Niekerk CJ, Gilhofer T, Ha G, D'Ambrosio G, et al. . Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion. Europace. EPUB ahead of print: 27 October 2023. - PMC - PubMed
    1. Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K, et al. . Chronic kidney disease and cerebrovascular disease. Stroke 2021;52:e328–46. - PubMed
    1. Michlicka-Kłyś W, Kalarus Z, Podolecki T, Mitręga K, Streb W. Long-term results of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and chronic kidney disease. Adv Interven Cardiol 2022;18:43–9. - PMC - PubMed
    1. Lutz J, Jurk K, Schinzel H. Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations. Int J Nephrol Renovasc Dis 2017;10:135–43. - PMC - PubMed
    1. Cases A, Gomez P, Broseta JJ, Perez Bernat E, Arjona Barrionuevo JD, et al. . Non-valvular atrial fibrillation in CKD: role of vitamin K antagonists and direct oral anticoagulants. A narrative review. Front Med (Lausanne) 2021;8:654620. - PMC - PubMed

MeSH terms